Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Regeneron Pharm

Article Abstract:

Regeneron Pharmaceuticals, Inc. is engaged in the commercialization of therapeutic drugs. A comparative analysis of the company sales and financial details of from 1991 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Regeneron Pharm.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Regeneron Pharmaceuticals Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

West Pharm.: NYSE - WST

Article Abstract:

A comparative analysis of the company sales and financial details of West Pharm from 1988 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Liew Van, C. Nils
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Comparative analysis, West Pharmaceutical Services Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
  • Abstracts: Steris Corp. Steris Corp.: NYSE - STE
  • Abstracts: VISX, Inc.: NYSE - EYE. Charles River laboratories Int'l
  • Abstracts: Varian Medical. Varian Medical: NYSE-VAR
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.